Vimarsana
Biggest News Aggregation in the World

Page 7 - Thomas Triomphe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas Triomphe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Triomphe Today - Breaking & Trending Today

Beyfortus Approved to Prevent RSV Disease in Infants and Toddlers - Vimarsana News

Beyfortus Approved to Prevent RSV Disease in Infants and Toddlers

Beyfortus (nirsevimab-alip) is approved for the prevention of RSV lower respiratory tract disease in infants and children up to 24 months of age.

Source: empr.com
FDA Approves RSV Vaccine for All Infants - Vimarsana News

FDA Approves RSV Vaccine for All Infants

The new monoclonal antibody carries a broader indication than the existing vaccine against RSV for infants.

FDA approves new drug to protect babies from RSV - Vimarsana News

FDA approves new drug to protect babies from RSV

Respiratory syncytial virus is the leading cause of hospitalization in American infants.

FDA approves new drug to protect babies from RSV - Vimarsana News

FDA approves new drug to protect babies from RSV

Respiratory syncytial virus is the leading cause of hospitalization in American infants.

FDA approves Sanofi-AstraZeneca's preventive RSV therapy for children - Vimarsana News

FDA approves Sanofi-AstraZeneca's preventive RSV therapy for children

AstraZeneca and Sanofi stated that a single dose demonstrated “high and consistent efficacy” against RSV LRTD and that they plan to make Beyfortus available in the U.S. by the fall.